Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Vitamin D Levels in African Americans
NCT04939792Phase 1Completed
- Sponsor
- LSU Health Shreveport
- Start
- Nov 2020
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial (4 arms), sponsored by LSU Health Shreveport. Primary endpoint: 25-hydroxy-vitamin D at 6 months. Started Nov 2020; status: completed.
Beyond the preview
Go deeper on NCT04939792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939792.